OLCC Commissioners Ratify Stipulated Settlement On Recreational Marijuana License

OREGON:  At its monthly meeting April 19, 2018, the Commissioners of the Oregon Liquor Control Commission ratified the following fines and/or marijuana license suspensions and destruction orders based on stipulated settlement:

Jenny’s Dispensary, Deschutes County; will pay a fine of $6,105 or serve a 37-day recreational marijuana retailer license suspension for two violations.  The first violation is for the licensee or its employees, agents, or representatives failing to keep surveillance recordings for a minimum of 90 calendar days.

The second violation is for is for the licensee or its employees, agents, or representatives failing to store marijuana items for sale in such a manner that the items were only accessible to authorized representatives until such time as the final sale to the consumer was completed.  Licensee is Jenny’s of Oregon, Inc.; David Rosen, President/Secretary.

CBD Oil; permitted its processor license to expire, accepted a Letter of Reprimand for the charged violations, and withdrew its request for a hearing for four violations.  The first violation is for the licensee or its employees, agents, or representatives operated other than as its license permits by delivering marijuana items to or on an area that was not a licensed premises, and/or by selling, transferring, delivering, transporting, purchasing, or receiving marijuana items other than as provided in OAR 845-025-3215(1), when it sold, transferred, delivered and transported the product “Modern Medicinals CBD Oil,” a cannabinoid extract, to non-licensed retailers and entities including, without limitation, Mandala Medicine & Wellness in Portland, Oregon, and Salem Hypnosis Solutions in Salem, Oregon.

The second violation is for the licensee or its employees, agents, or representatives intentionally failed to accurately enter data into the cannabis tracking system (CTS) that fully and transparently accounted for all inventory tracking activities, by adjusting the weight of packages in order to divert product out of the licensed system and elude the seed-to-sale CTS.

The third violation is for the licensee or its employees, agents, or representatives failed to accurately enter data into the cannabis tracking system (CTS) that fully and transparently accounted for all inventory tracking activities, by failing to finish and create manifests for 32 packages in its CTS inventory that were not present on the licensed premises on October 24, 2017, and that licensee claimed to have shipped on October 23, 2017; by failing to discontinue packages in CTS that had no content; and by failing to account for at least seven missing packages that did have content according to CTS.

The fourth violation is for the licensee or its employees, agents, or representatives distributed printed materials advertising its recreational marijuana product “CBD Oil” as having “comprehensive pain relief properties” and “medicinal effects” such as “relieves pain and inflammation,” “has antipsychotic effects,” “reduces anxiety,” “helps fight cancer,” “relieves nausea,” “may treat seizures and other neurological disorders,” and “promotes cardiovascular health.” On or about December 1, 2017, Licensee’s website claimed that its recreational marijuana product “CBD Oil” has curative or therapeutic effects in that it was stated to be highly effective in treating pain.

Licensee is Modern Medicinals, LLC; Jeffrey Hilber, Managing Member.

Medigreen Collective, Multnomah County; will surrender its retail license upon the transfer of ownership of the business for one violation, which was the licensee’s thirdCategory I violation within two years.

The violation is for the licensee or its employees, agents, or representatives failing to keep surveillance recordings for a minimum of 90 calendar days.  Licensee agrees to accept a Letter of Reprimand for this violation.  This reprimand will become a permanent part of Licensee’s Commission file and may be considered in any future application for any license by Licensee.  Licensee is MTO Holdings, Inc., Luay Tomeka, President/Stockholder.

 

Israel’s Tikun Olam Continues U.S. Expansion

Deal with DC Cultivator Alternative Solutions Brings Renowned Cannabis Products to the Nation’s Capital 

NEW YORK:  Tikun Olam, a leading Israeli cannabis brand and pioneer in cannabis research, continues its U.S. expansion by partnering with Washington DC cultivator Alternative Solutions. The just-inked licensing deal allows Alternative Solutions to grow, manufacture and distribute Tikunbranded products to all five District of Columbia dispensaries.

Tikun Olam’s award-winning premium cannabis products are backed by years of peer-reviewed scientific research and unprecedented clinical data collection, which has shown to deliver symptomatic relief to those suffering from specific conditions such as cancer, PTSD, epilepsy, Crohn’s Disease/Colitis, chronic pain and neuropathy, to name a few. At the  held November 30 in Toronto, Tikun strains took First place in three categories: Top High THC Flower (Eran Almog), Top High CBD Flower  (Avidekel), and Top High CDB Oil (Avidekel), in addition to placing Second in Top Hybrid Flower (Midnight). Tikun’s full line of proprietary strain products–from flower, vape, topicals and tinctures–will be available in Washington DC  beginning in 2018.

“Alternative Solutions is thrilled to be Tikun Olam’s exclusive partner in DC,” says Matt Lawson-Baker, COO of Alternative Solutions. “We look forward to making Tikun’s products available at all DC dispensaries, giving access to these clinically proven strains to the more than 5,600 registered MMJ patients in Washington DC.”

The new five-year deal with Alternative Solutions is the latest in a series of licensing agreements struck since Tikun’s U.S. launch in 2015 in Delaware. The recent announcement with the MariMed cannabis network will introduce Tikun’s exclusive strains and products in medical marijuana dispensaries in Rhode Island, Maryland, Massachusetts and Illinois in 2018. Tikun™ products also launched in Nevada in March 2017 and in Washington State in November.

The Growth Of The Hemp CBD Markets

NEW YORK: According to a research conducted by Hemp Business Journal and Vote Hemp, the Hemp CBD is a market with $130 million in sales with growth at a 53% AGR (Adjusted Growth Revenue). This as a result contributed to the $688 million in total Hemp sales in 2016.

The Hemp CBD category was led by channel sales in natural and specialty products such as smoke shops and online verticals. As well in 2016, SPINS, the leading market research firm for natural products, has listed that $2,470,000 worth of products has used CBD as a primary ingredient. Currently CBD-based pet care products are a ‘growth category to watch’ in 2017.

Eric Steenstra, President of Vote Hemp has referenced, “To date, 31 states have passed legislation that allows hemp farming per provisions set forth in the 2014 Farm Bill, and the U.S. remains the largest consumer market for hemp products worldwide. We need Congress to pass federal legislation to allow commercial hemp farming nationally, to let our farmers and American businesses take advantage of the robust economic opportunity hemp provides.”